Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodefciency virus status: analysis from under five children

Show simple item record

dc.contributor.author JOANNE A. HASSAN
dc.contributor.author Laura Wangai, Peter Borus4, Christopher Khayeka–Wandabwa5, Lucy Wanja Karani, Mercy Kithinji and Michael Kiptoo
dc.date.accessioned 2025-04-09T07:22:55Z
dc.date.available 2025-04-09T07:22:55Z
dc.date.issued 2017
dc.identifier.uri https://bmcresnotes.biomedcentral.com/counter/pdf/10.1186/s13104-017-2843-y.pdf
dc.identifier.uri http://repository.kemri.go.ke:8080/xmlui/handle/123456789/1412
dc.description.abstract Background: Poliomyelitis is an acute viral infection caused by poliovirus and transmitted via the fecal–oral route. The causative agent is one of the three serotypes of poliovirus (serotypes 1, 2, 3) that difer slightly in capsid protein. Prolonged vaccine-related poliovirus shedding in human immunodefciency virus (HIV) positive individuals has been linked to possible reservoir for reintroduction of polioviruses after eradication. The study therefore aimed at estimating the duration for vaccine-related poliovirus shedding among potentially and HIV-infected persons. Methods: Poliovirus excretion was studied following vaccination of children aged ≤ 59 month per human immunodefciency virus status after national immunization days. Their medical records were reviewed to identify the child’s HIV status, demographic and immunization data. Sequential stool samples were collected at site 2nd, 4th and 8th week after trivalent oral poliovirus vaccine (tOPV) was administered. To isolate suspected polioviruses and non-polio enteroviruses, characterize poliovirus subtypes by intratypic diferentiation and Sabin vaccine derived poliovirus, real time polymerase chain reaction was applied. Shedding for ≥ 24 weeks was defned as long-term persistence. Results: The mean age of the study population was 28.6 months, while the median age was 24 months. Of the children recruited, majority were in the 25–48 months (n = 12; 46.2%) age category. All the HIV-positive children (n = 10) had mild symptomatic HIV status and did shed vaccine-related polioviruses between weeks 2 and 4 respectively. No participant shed polioviruses for ≥ 6 weeks. Conclusions: It was evident mildly symptomatic HIV+ children sustain the capacity to clear vaccine-related poliovirus. The oral poliovirus vaccine-2 (Sabin like) that was detected in one HIV-infected child’s stool 6 weeks after the national immunization days was predominantly non revertant. There was no evident prolonged poliovirus shedding among the participants enlisted in the present study. High powered studies are desired to further corroborate these findings. en_US
dc.language.iso en en_US
dc.publisher BioMed Central Research Journal en_US
dc.subject Poliomyelitis, Poliovirus, Poliovirus shedding, HIV, Immunization, Vaccination, Real time polymerase chain reaction en_US
dc.title Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodefciency virus status: analysis from under five children en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

  • Journals and Articles
    This is a collection of journals published by KEMRI Graduate School students, fulll access to the article can be access through the link provided.

Show simple item record

Search DSpace


Advanced Search

Browse

My Account